Endosense(瑞士)

Endosense

Endosensewww.endosense.comEndosense于2003年在日內瓦成立，是一家醫療科技公司，致力于改善治療心律失常的導管消融術的功效、安全性和易用性。公司在開發TactiCath*時率先在導管消融術中采用了觸點壓力測量，TactiCath是種壓敏消融導管，允許醫生在實施導管消融術時實時、客觀地測量接觸力。Endosense得到EdmonddeRothschildInvest mentPartners、Neomed、Gimv、VIPartners、SectoralAssetManagement、YsiosCapitalPartners及InitiativeCapitalRomandie等投資公司的投資支持。Endosenseisamedicaltechnologycompanyfocusedonimprovingtheefficacy,safetyandreproducibilityofcatheterablationforthetreatmentofcardiacarrhythmias.ThecompanyhaspioneeredtheuseofContactForceincatheterablation.Thecompany’sflagshipproductistheTactiCathQuartz®,thefirstforce-sensingablationcathetertogivephysiciansareal-time,objectivemeasureofcontactforceduringthecatheterablationprocedure.AlreadydistributedinEurope,AustraliaandNewZealand,thisforce-sensingcatheterhasundergoneextensivepre-clinicalandclinicalvalidation.Endosense’star